Observational studyNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Impact of time from symptom onset to recanalization in acute anterior circulation large vessel occlusive stroke with same tissue window: A patient-level pooled analysis of the three randomized controlled trials.
Observational study in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although multimodal imaging extends the thrombectomy window to 24 h based on tissue viability, the prognostic value of shorter onset-to-recanalization times within this window is unclear. Using pooled trial data, we assessed this association in patients meeting Alberta Stroke Program Early CT Score [ASPECTS] ≥6. We conducted a patient-level pooled analysis of three multicenter randomized trials: DEVT, RESCUE BT, and MARVEL. Multivariable analysis was conducted to evaluate the association between the time from symptom onset to recanalization and 90-day functional independence (modified Rankin Scale [mRS] score of 0-2 and 0-1), any intracranial hemorrhage, and 3-month mortality. Restricted cubic splines were used to model the continuous relationship and identify optimal time thresholds. Among 1931 patients, a shorter onset-to-recanalization time was independently associated with better outcomes. Compared to the >6-12 h and >12-24 h intervals, recanalization within ≤6 h was associated with higher odds of mRS 0-2 (adjusted odds ratio [OR] 0.66, 95% CI 0.53-0.82, p < 0.01; and adjusted OR 0.59, 95% CI 0.45-0.79, p < 0.01, respectively). A significant non-linear relationship was observed (P for nonlinearity = 0.008). The >6-12 h window was associated with increased mortality (adjusted OR 1.53, 95% CI 1.02-2.28, P = 0.04) and symptomatic intracranial hemorrhage (adjusted OR 1.66, 95% CI 1.32-2.09, p < 0.01). Our analysis revealed a more pronounced association between onset-to-recanalization time and 90-day functional outcomes than previously recognized. Among patients with ASPECTS ≥6 undergoing thrombectomy, expedited treatment was strongly linked to substantially improved neurological recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.